Immunogenomics papers: Difference between revisions
From genomewiki
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
* [http://stm.sciencemag.org/content/1/12/12ra23 Boyd et al, Fire lab, Stanford] | * [http://stm.sciencemag.org/content/1/12/12ra23 Boyd et al, Fire lab, Stanford] | ||
** sequenced IGH-locus with BIOMED2 primers | ** sequenced IGH-locus with BIOMED2 primers | ||
* [http://bioinformatics.oxfordjournals.org/content/26/24/3129.full, Bioinformatics 2011, Collins lab, Stanford] | |||
** Benchmark of IGH-identifiers | |||
* [http://www.ncbi.nlm.nih.gov/pubmed/8601832 Tomlinson 1996] | * [http://www.ncbi.nlm.nih.gov/pubmed/8601832 Tomlinson 1996] | ||
** Sanger sequencing of <1000 IGH sequences | ** Sanger sequencing of <1000 IGH sequences | ||
Latest revision as of 01:32, 23 August 2011
- Boyd 2010 J of Immunol, Collins lab, Stanford
- sequenced IGH with BIOMED2 primers of 12 people
- describe variation
- Boyd et al, Fire lab, Stanford
- sequenced IGH-locus with BIOMED2 primers
- Bioinformatics 2011, Collins lab, Stanford
- Benchmark of IGH-identifiers
- Tomlinson 1996
- Sanger sequencing of <1000 IGH sequences
- compare germline mutations (=IMGT) versus somatic mutations
- In parts of antibody where there is little germline variation, there is lots of somatic mutations, and the inverse
- Glanville 2009, Pons lab, Pfizer
- Zemlin 2003
- CDR3 composition is very different between human and mouse
